Intelligence · Clinical Development
Pipeline search results
Programs matching “msc” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 43 pipeline programs matching "msc" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
NurOwn (MSC-NTF cells)
BRAINSTORM CELL THERAPEUTICS INC.
Multiple Sclerosis, Chronic Progressive
1 trial -
UC-MSC transplantation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Liver Cirrhosis
1 trial -
UC-MSCs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cirrhosis Due to Hepatitis B
1 trial -
WJMSCs Vs. placebo
The First People's Hospital of Lianyungang
Ischemic Cardiomyopathy
1 trial -
allogeneic human mesenchymal stem cells (hMSCs)
United Therapeutics Europe Ltd
Non-ischemic Dilated Cardiomyopathy
1 trial -
conventional therapy plus low dose hUC-MSCs treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Liver Cirrhosis
1 trial -
Allogeneic (MSC's) Application to the Burn Wounds
United Therapeutics Europe Ltd
Skin Burn Degree Second
1 trial -
Allogeneic MSC
United Therapeutics Europe Ltd
Mesenchymal Stromal Cells
1 trial -
MCA-derived MSC therapy in renal transplant recipients
Disc Medicine
Rejection transplanted kidney, BPAR
1 trial -
MSC-derived exosomes
Regeneron Ireland Designated Activity Company (DAC)
Long COVID-19 Syndrome
1 trial -
MSC2156119J
Merck KGaA, Darmstadt, Germany
Solid Tumors
1 trial -
MSCs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
MSCs-derived exosomes
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronavirus
1 trial -
NeuroRegen scaffold with BMMCs or MSCs transplantation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Spinal Cord Injury
1 trial -
UCMSC
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bronchopleural Fistula
1 trial -
human Mesenchymal Stem Cell (MSC) infusion therapy
CytoMed Therapeutics Ltd
Aging Well
1 trial -
ucMSCs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bronchopulmonary Dysplasia
1 trial -
mesenchymal stromal cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
MSC
1 trial -
UC-MSCs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
2019 Novel Coronavirus Pneumonia
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.